Clinical outcomes and survival differences between primary, secondary and concomitants carcinoma in situ of urinary bladder treated with BCG immunotherapy

BACKGROUND: The carcinoma in situ (CIS) of urinary bladder is a flat, high-grade and aggressive manifestation of urothelial cancer which carries a great risk for progression to muscle invasive disease and metastatic spread. The aim of the study was to analyse the clinical history and survival differ...

Descripción completa

Detalles Bibliográficos
Autores principales: Piszczek, Radosław, Krajewski, Wojciech, Małkiewicz, Bartosz, Krajewski, Piotr, Tukiendorf, Andrzej, Zdrojowy, Romuald, Kołodziej, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354324/
https://www.ncbi.nlm.nih.gov/pubmed/32676418
http://dx.doi.org/10.21037/tau.2020.03.40

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354324/
https://www.ncbi.nlm.nih.gov/pubmed/32676418
http://dx.doi.org/10.21037/tau.2020.03.40

Ejemplares similares